Egret Medical S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers

Secondary Activities: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers | Electrical Apparatus and Equipment, Wiring Supplies, and Related Equipment Merchant Wholesalers | Apparel, Piece Goods, and Notions Merchant Wholesalers | Footwear Merchant Wholesalers | Miscellaneous Nondurable Goods Merchant Wholesalers | Health and Personal Care Stores | Pharmacies and Drug Stores

Full name: Egret Medical S.A.

Profile Updated: September 08, 2025

Egret Medical S.A. is a company based in Ecuador, with its head office in Quito. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on August 10, 2023. It currently has a total number of 3 (2024) employees. Its total assets grew by 921.18% over the same period.

Headquarters
Calle Baquerizo Moreno, N24F
Quito; Pichincha;

Contact Details: Purchase the Egret Medical S.A. report to view the information.

Basic Information

Total Employees:

Purchase the Egret Medical S.A. report to view the information.

Registered Capital:

Purchase the Egret Medical S.A. report to view the information.

Financial Auditors:

Purchase the Egret Medical S.A. report to view the information.

Incorporation Date:

August 10, 2023

Key Executives

Purchase this report to view the information.

President

Ownership Details

Purchase this report to view the information.

99.98%

Purchase this report to view the information.

0.02%

Company Performance

Financial values in the chart are available after Egret Medical S.A. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.

Operating profit (EBIT)

-431.77%▼

EBITDA

-431.77%▼

Net Profit (Loss) for the Period

-447.87%▼

Total Assets

921.18%▲

Total Equity

N/A

Return on Equity (ROE)

N/A

Similar companies